Company: SNSE
Filing Date: 2025-05-23
Form Type: 8-K
Source: 0001193125-25-125484
Chunk: 1

Company: Sensei Biotherapeutics, Inc.
Filing Date: 2025-05-23
Form: 8-K
Item: Item 5.07
Chunk 1
---
 14,694,068          1,602,413        321,333  

Proposal No. 3 was approved.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                          Sensei Biotherapeutics, Inc.   
  Date: May 23, 2025      /s/ Christopher W. Gerry       
                          Christopher W. Gerry           
                          General Counsel and Secretary